111 related articles for article (PubMed ID: 3514543)
1. Bornaprine vs placebo in Parkinson disease: double-blind controlled cross-over trial in 30 patients.
Cantello R; Riccio A; Gilli M; Delsedime M; Scarzella L; Aguggia M; Bergamasco B
Ital J Neurol Sci; 1986 Feb; 7(1):139-43. PubMed ID: 3514543
[TBL] [Abstract][Full Text] [Related]
2. [Bornaprine in the treatment of parkinsonian tremor].
Piccirilli M; D'Alessandro P; Testa A; Piccinin GL; Agostini L
Riv Neurol; 1985; 55(1):38-45. PubMed ID: 3895365
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of bornaprine on parkinsonian tremor.
Sancesario G; Cicardi MC; Fiermonte G; Giacomini P; Stanzione P
Ital J Neurol Sci; 1984 Sep; 5(3):289-93. PubMed ID: 6500902
[TBL] [Abstract][Full Text] [Related]
4. [Preliminary open multicenter study on the anti-tremorigenic effectiveness of bornaprine (Sormodren)].
Bergamasco B; Cantello R; Delsedime M; Gilli M; Riccio A; Aguggia M
Minerva Med; 1985 Oct; 76(40):1877-81. PubMed ID: 4058785
[TBL] [Abstract][Full Text] [Related]
5. [Kr 339 in the treatment of parkinsonian tremor].
Iivanainen M
Duodecim; 1974; 90(8):590-6. PubMed ID: 4605767
[No Abstract] [Full Text] [Related]
6. Low-dose bromocriptine therapy in Parkinson's disease: double-blind, placebo-controlled study.
Staal-Schreinemachers AL; Wesseling H; Kamphuis DJ; vd Burg W; Lakke JP
Neurology; 1986 Feb; 36(2):291-3. PubMed ID: 3511405
[TBL] [Abstract][Full Text] [Related]
7. KR 339 in the treatment of Parkinsonian tremor.
Iivanainen M
Acta Neurol Scand; 1974; 50(4):469-77. PubMed ID: 4604665
[No Abstract] [Full Text] [Related]
8. Clinical evaluation of the antidepressants: maprotiline and amitriptyline. A double-blind controlled trial.
Marais GF
S Afr Med J; 1974 Jul; 48(36):1530-2. PubMed ID: 4608286
[No Abstract] [Full Text] [Related]
9. Bromocriptine in the treatment of advanced Parkinsonism.
Kristensen O; Hansen E
Acta Neurol Scand; 1977 Sep; 56(3):274-6. PubMed ID: 333856
[TBL] [Abstract][Full Text] [Related]
10. Bromocryptine in levodopa response-losing parkinsonism. A double blind study.
Jansen EN
Eur Neurol; 1978; 17(2):92-9. PubMed ID: 344042
[TBL] [Abstract][Full Text] [Related]
11. Effects of bromocriptine on parkinsonism. A nation-wide collaborative double-blind study.
Toyokura Y; Mizuno Y; Kase M; Sobue I; Kuroiwa Y; Narabayashi H; Uono M; Nakanishi T; Kameyama M; Ito H
Acta Neurol Scand; 1985 Aug; 72(2):157-70. PubMed ID: 3901650
[TBL] [Abstract][Full Text] [Related]
12. Two weeks of treatment with deprenyl (selegiline) does not prolong L-dopa effect in parkinsonian patients: a double-blind cross-over placebo-controlled trial.
Rascol O; Montastruc JL; Senard JM; Demonet JF; Simonetta M; Rascol A
Neurology; 1988 Sep; 38(9):1387-91. PubMed ID: 3137488
[TBL] [Abstract][Full Text] [Related]
13. Dopaminergic agonist Ro 8-4650 in Parkinson's disease. II. Patients not treated with dopa.
Presthus J; Ankerhus J; Burén A; Bøttcher J; Holmsen R; Mikkelsen B; Mikkelsen BO; Nyberg-Hansen R; Riman E; Severin B; Aarli JA
Acta Neurol Scand; 1978 Jul; 58(1):77-9. PubMed ID: 360760
[TBL] [Abstract][Full Text] [Related]
14. Bromocriptine: low-dose therapy in Parkinson disease.
Teychenne PF; Bergsrud D; Racy A; Elton RL; Vern B
Neurology; 1982 Jun; 32(6):577-83. PubMed ID: 7201089
[TBL] [Abstract][Full Text] [Related]
15. Dopaminergic agonist Ro 8-4650 in Parkinson's disease. I. Patients treated with dopa.
Birket-Smith E; Bøttcher J; Dupont E; Holm P; Jensen JP; Kristensen O; Køhler O; Mikkelsen B
Acta Neurol Scand; 1978 Jul; 58(1):74-6. PubMed ID: 360759
[TBL] [Abstract][Full Text] [Related]
16. Simplification of the initiation of bromocriptine in elderly patients with advanced Parkinson's disease.
MacMahon DG; Overstall PW; Marshall T
Age Ageing; 1991 Mar; 20(2):146-51. PubMed ID: 2053506
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of an experimental anticholinergic drug, elantrine, in treating the tremor of parkinsonism.
Rix A
Adv Exp Med Biol; 1977; 90():277-81. PubMed ID: 337773
[TBL] [Abstract][Full Text] [Related]
18. Bromocriptine versus placebo in levodopa treated patients with Parkinson's disease.
Gron U
Acta Neurol Scand; 1977 Sep; 56(3):269-73. PubMed ID: 333855
[TBL] [Abstract][Full Text] [Related]
19. Peripheral beta-adrenergic blockade treatment of parkinsonian tremor.
Foster NL; Newman RP; LeWitt PA; Gillespie MM; Larsen TA; Chase TN
Ann Neurol; 1984 Oct; 16(4):505-8. PubMed ID: 6149724
[TBL] [Abstract][Full Text] [Related]
20. A double-blind study of bromocriptine and L-dopa in de novo Parkinson's disease. Short-term results.
Riopelle RJ; Gawel MJ; Libman I; King DB; McLean DR; Paulseth R; Raphy B; Bouchard S
Eur Neurol; 1988; 28 Suppl 1():11-4. PubMed ID: 3288477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
